The party has reserved 2 seats each for Ajit Singh’s RLD and Sharad Yadav’s LJD and one seat for Sharad Pawar’s NCP.

Most MNCs have been facing heat due to fast expiring patents, challenges in new drug discovery and depleting product pipeline.

The rejection of the Glivec patent has added to pharma MNCs’ woes after a slew of measures in the past one year.

ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.

A creeping acquisition has begun in the shares of Chennai-based Orchid Chemicals & Pharmaceuticals which has become vulnerable to acquisiti...

Innovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing...

Serious talent shortage and lack of experienced manpower, especially in emerging sectors like retail is pushing companies like Dabur, Tesco...

Pharma firms have decided to restrict travel, gifts and shopping expenses offered to doctors.

Industry body OPPI has said the proposed policy will hamper the growth of the pharmaceutical sector and lead to the destruction of Indian p...

Drugmakers have demanded concessions for R&D, customs duty rationalisation and duty waivers for life-saving drugs in this Budget. They are ...